What are Mission Vision & Core Values of West Pharmaceutical Services Company?

What drives West Pharmaceutical Services forward?

West Pharmaceutical Services anchors its strategy in patient safety, precision manufacturing, and long-term partnerships with top pharma and biotech firms. These pillars guide product quality and regulatory excellence across global injectable drug delivery solutions.

West’s mission focuses on ensuring safe delivery of medicines; its vision emphasizes innovation and global leadership; core values prioritize quality, integrity, and customer collaboration to support complex biologics and GLP-1 therapies.

Explore an analysis of West’s competitive position: West Pharmaceutical Services Porter's Five Forces Analysis

West focuses on partnering with leading pharmaceutical and biotech firms to deliver high-quality injectable solutions, driving innovation in containment and patient safety within the injectable medicines market.

Target Customers

Partners with top global pharmaceutical and biotechnology companies to serve the injectable medicines sector.

Market Scope

Specializes in high-barrier injectable containment and delivery systems for biologics and small molecules.

Product Focus

Proprietary Products represent about 80% of net sales (2024–2025 focus), emphasizing in-house innovation.

Quality by Design

NovaPure components use QbD to reduce particulate contamination and meet stringent pharma standards.

Patient Centricity

Success measured by safe delivery of medications to patients and improved therapeutic outcomes.

Trusted Partnership

Positions itself as a collaborative partner, not just a vendor, to drive client product success.

West’s mission aligns innovation, quality, and patient safety to support biologics and injectable drug delivery, reflecting its guiding principles and corporate purpose.

Further context and history available: Brief History of West Pharmaceutical Services

Complete West Pharmaceutical Services Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

To be the world leader in integrated solutions for injectable drug delivery, advancing wearable injectors, digital health and patient-centric care while growing global market share.

Market leadership

Ambition to lead the injectable delivery market with integrated hardware, software and services.

Product evolution

Shift from component manufacturing to end-to-end solutions including SmartDose wearable injectors.

Patient-centricity

Focus on home-based care and self-administration for chronic disease management.

Digital integration

Integrating electronics and data to support decentralized trials and remote monitoring.

R&D investment

Annual R&D spend exceeds $60,000,000, supporting innovation toward SmartDose and wearable platforms.

Financial footing

2024 net sales near $3,000,000,000, providing resources to pursue strategic vision and market expansion.

To be the world leader in integrated solutions for injectable drug delivery, advancing wearable injectors, digital health and patient-centric care while growing global market share.

Mission, Vision & Core Values of West Pharmaceutical Services

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

West Pharmaceutical Services core values guide daily decisions and define the company’s purpose, culture and ethical standards. These principles support West Pharmaceutical Services mission and West Pharmaceutical Services vision while driving product safety, customer partnerships and sustainable growth.

West Pharmaceutical Services operates under four core values that define its corporate culture and operational standards.

Passion for Customers

West partners closely with biotech and pharma clients through co-development and rapid scale-up programs; in 2024 it expanded capacity to support surging demand for GLP-1 therapies, preserving critical supply chains.

Leadership in Quality

Quality is non-negotiable: West applies Six Sigma methods, automated vision inspection and strict FDA/EMA compliance across 25+ global sites, scanning billions of components annually to minimize defects.

One West Team

With over 10,000 employees worldwide, West promotes cross-functional collaboration and standardized processes that enable seamless production transfers between regions during crises or demand surges.

Integrity

Integrity shows in transparent ESG reporting and ethical sourcing; West’s 2024 Sustainability Report details targets to reduce emissions and waste, reinforcing trust with regulators and investors.

Explore how West Pharmaceutical Services mission and West Pharmaceutical Services vision shape product strategy, R&D priorities and investor decisions; read the next chapter to see how values influence strategic choices and performance metrics.

Values West Pharmaceutical Services operates under four core values that define its corporate culture and operational standards.

Passion for Customers This value manifests in West’s co-development programs, where engineers work directly with biotech firms during the early stages of drug development. In 2024, this was exemplified by West’s rapid scaling of production capacity to meet the unprecedented demand for GLP-1 weight-loss and diabetes medications, ensuring customers could maintain their supply chains during critical growth phases.

Leadership in Quality Quality is the non-negotiable core of West’s identity. The company employs advanced Six Sigma methodologies and maintains rigorous compliance with FDA and EMA standards across its 25+ global manufacturing sites. This value is demonstrated through their zero-defect initiatives and the implementation of automated vision inspection systems that scan billions of components annually to ensure patient safety.

One West Team This value promotes a culture of global collaboration and inclusivity. With over 10,000 employees worldwide, West utilizes cross-functional teams to solve complex logistics and engineering challenges. It manifests in the company’s unified response to global health crises and its standardized manufacturing processes, which allow for seamless production transfers between regions like North America and Asia-Pacific.

Integrity Integrity is reflected in West’s transparent ESG reporting and ethical sourcing practices. The company’s 2024 Sustainability Report highlights a commitment to reducing carbon emissions and waste, aligning business ethics with environmental stewardship. This value differentiates West from competitors by building long-term trust with regulators and investors who prioritize corporate responsibility.

These values collectively create a unique corporate identity that balances high-stakes engineering with a deeply humanistic purpose, distinguishing West from more diversified industrial manufacturers. Read more context on ownership and governance in Owners & Shareholders of West Pharmaceutical Services

West Pharmaceutical Services Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Mission and vision statements shape West Pharmaceutical Services' strategic decisions by directing capital allocation, R&D priorities and M&A to align with long-term patient-focused goals. They translate corporate purpose into measurable investments and daily operational choices.

Mission, Vision & Core Values — At a Glance

Clear guiding statements drive product strategy, manufacturing investment and innovation priorities.

• Mission emphasizes patient-first integrated delivery solutions and system-level thinking
• Vision targets leadership in integrated solutions for biologics and specialty drug delivery
• Core values center on quality, integrity, collaboration and continuous improvement
• Strategic choices prioritize high-value products, digital connectivity and containment for biologics

Capital Allocation

Over 350 million dollars allocated in the 2024–2025 CAPEX plan to expand HVP manufacturing capacity, reflecting the vision to lead in integrated biologics solutions.

Product Mix Focus

HVP net sales now represent over 70 percent of Proprietary Products segment revenue, showing measurable alignment with strategic priorities.

R&D Prioritization

R&D investments target delivery challenges like stability of highly concentrated protein formulations, guided by the mission to solve patient needs.

M&A and Technology

Acquisitions emphasize technologies that enhance digital health connectivity and data-driven delivery devices to support the company vision.

Leadership Message

CEO Eric Green and other leaders link growth outcomes to the patient-first mission and emphasize values-driven decision-making.

Operational Impact

Day-to-day operations prioritize projects with highest patient and product impact, demonstrating how West Pharmaceutical Services mission and West Pharmaceutical Services vision shape execution.

Read more on how strategy ties to revenue streams in this detailed article: Revenue Streams & Business Model of West Pharmaceutical Services

The mission and vision directly influenced the 2024–2025 CAPEX of $350M+, drove HVP share to 70%+ of Proprietary Products revenue, and shaped R&D and acquisitions to support integrated biologics delivery—read next: Core Improvements to Company's Mission and Vision.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE

Four focused improvements can strengthen West Pharmaceutical Services' mission, vision, and core values to meet 2025 healthcare demands. These enhancements emphasize digital integration, sustainability, customer-centric innovation, and measurable accountability.

Embed digital health and smart-device integration

Explicitly state commitment to connected drug delivery systems and digital health platforms to reflect the shift toward IoT-enabled therapeutics and increase alignment with customers seeking smart solutions.

Elevate environmental sustainability into the mission

Include targets for recycled materials, reduced Scope 1–3 emissions, and circular manufacturing principles to meet rising customer expectations and regulatory requirements for Net Zero alignment.

Make customer accessibility and global health equity explicit

Clarify a mission focus on improving global access to safe injections and biologics delivery, tying product development to measurable patient-outcome goals and underserved market access metrics.

Introduce measurable metrics and governance for values

Adopt clear KPIs for innovation, sustainability, and quality—reported annually—to operationalize West Pharmaceutical Services core values and link executive incentives to strategic outcomes.

Improvements: While West’s mission and vision are strong, adding explicit commitments to digital health integration and environmental sustainability would better align West Pharmaceutical Services mission and West Pharmaceutical Services vision with 2025 industry trends; peers like Becton Dickinson emphasize digital connectivity and access, so refining West Pharmaceutical Services core values to cover smart delivery systems and circular materials would future-proof strategy and support West Pharmaceutical Services company culture and purpose. See a related analysis in Growth Strategy of West Pharmaceutical Services. Current industry context: global injectable drug-device market projected to grow at ~6–7% CAGR through 2028 and pharmaceutical suppliers face rising buyer expectations for Scope 3 emissions disclosure and sustainable sourcing.